{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T02:47:14Z","timestamp":1794019634196,"version":"4.8.0"},"reference-count":84,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001407","name":"Department of Biotechnology, Ministry of Science and Technology, India","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001407","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002742","name":"Banaras Hindu University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002742","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001411","name":"Indian Council of Medical Research","doi-asserted-by":"publisher","award":["5\/3\/8\/23\/2020-ITR"],"award-info":[{"award-number":["5\/3\/8\/23\/2020-ITR"]}],"id":[{"id":"10.13039\/501100001411","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Biological Macromolecules"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1016\/j.ijbiomac.2025.144650","type":"journal-article","created":{"date-parts":[[2025,5,25]],"date-time":"2025-05-25T17:41:57Z","timestamp":1748194917000},"page":"144650","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"P1","title":["Targeting antioxidant defense system enzymes for Leishmaniasis treatment"],"prefix":"10.1016","volume":"316","author":[{"given":"Kushal","family":"Bora","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shankar Prasad","family":"Kanaujia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vikash Kumar","family":"Dubey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijbiomac.2025.144650_bb0005","unstructured":"WHO. Leishmaniasis. Available online: Leishmaniasis (who.int)."},{"issue":"2","key":"10.1016\/j.ijbiomac.2025.144650_bb0010","doi-asserted-by":"crossref","first-page":"354","DOI":"10.4269\/ajtmh.13-0320","article-title":"Molecular Mechanisms of In vitro Betulin-Induced Apoptosis of Leishmania donovani","volume":"90","author":"Saudagar","year":"2014","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"10.1016\/j.ijbiomac.2025.144650_bb0015","doi-asserted-by":"crossref","unstructured":"Singh N, Mishra BB, Bajpai S, Singh RK, Tiwari VK. Natural product-based leads to fight against leishmaniasis. Bioorg. Med. Chem. 2014Jan 1;22(1):18\u201345. doi:https:\/\/doi.org\/10.1016\/j.bmc.2013.11.048. Epub 2013 Dec 4. PMID: 24355247.","DOI":"10.1016\/j.bmc.2013.11.048"},{"issue":"5","key":"10.1016\/j.ijbiomac.2025.144650_bb0020","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/s40249-016-0112-2","article-title":"Current challenges in treatment options for visceral leishmaniasis in India: a public health perspective","volume":"8","author":"Singh","year":"2016","journal-title":"Infect. Dis. Poverty"},{"issue":"6","key":"10.1016\/j.ijbiomac.2025.144650_bb0025","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1016\/j.freeradbiomed.2008.05.028","article-title":"Insights into the redox biology of Trypanosoma cruzi: trypanothione metabolism and oxidant detoxification","volume":"45","author":"Irigo\u00edn","year":"2008","journal-title":"Free Radic. Biol. Med."},{"issue":"1","key":"10.1016\/j.ijbiomac.2025.144650_bb0030","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1080\/21505594.2021.1896830","article-title":"Catalase impairs Leishmania mexicana development and virulence","volume":"12","author":"S\u00e1dlov\u00e1","year":"2021","journal-title":"Virulence"},{"key":"10.1016\/j.ijbiomac.2025.144650_bb0035","doi-asserted-by":"crossref","unstructured":"Van Assche T, Deschacht M, da Luz RA, Maes L, Cos P. Leishmania-macrophage interactions: insights into the redox biology. Free Radic. Biol. Med. 2011Jul 15;51(2):337\u201351. doi:https:\/\/doi.org\/10.1016\/j.freeradbiomed.2011.05.011. Epub 2011 May 14. PMID: 21620959.","DOI":"10.1016\/j.freeradbiomed.2011.05.011"},{"issue":"Pt 3","key":"10.1016\/j.ijbiomac.2025.144650_bb0040","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1042\/bj20021684","article-title":"Role of superoxide dismutase in survival of Leishmania within the macrophage","volume":"369","author":"Ghosh","year":"2003","journal-title":"Biochem. J."},{"key":"10.1016\/j.ijbiomac.2025.144650_bb0045","doi-asserted-by":"crossref","unstructured":"Mittra B, Laranjeira-Silva MF, Miguel DC, Perrone Bezerra De Menezes J, Andrews NW. The iron-dependent mitochondrial superoxide dismutase SODA promotes Leishmania virulence. J Biol Chem. 2017Jul 21;292(29):12324\u201312338. doi:https:\/\/doi.org\/10.1074\/jbc.M116.772624. Epub 2017 May 26. PMID: 28550086; PMCID: PMC5519379.","DOI":"10.1074\/jbc.M116.772624"},{"issue":"1","key":"10.1016\/j.ijbiomac.2025.144650_bb0050","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1186\/s13071-021-04838-8","article-title":"Downregulation of FeSOD-A expression in Leishmania infantum alters trivalent antimony and miltefosine susceptibility","volume":"14","author":"Santi","year":"2021","journal-title":"Parasit. Vectors"},{"issue":"2","key":"10.1016\/j.ijbiomac.2025.144650_bb0055","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1042\/BJ20061281","article-title":"Mitochondrial superoxide radicals mediate programmed cell death in Trypanosoma cruzi: cytoprotective action of mitochondrial iron superoxide dismutase overexpression","volume":"403","author":"Piacenza","year":"2007","journal-title":"Biochem. J."},{"key":"10.1016\/j.ijbiomac.2025.144650_bb0060","doi-asserted-by":"crossref","unstructured":"Ponte-Sucre A, Gamarro F, Dujardin JC, Barrett MP, L\u00f3pez-V\u00e9lez R, Garc\u00eda-Hern\u00e1ndez R, Pountain AW, Mwenechanya R, Papadopoulou B. Drug resistance and treatment failure in leishmaniasis: a 21st century challenge. PLoS Negl. Trop. Dis. 2017Dec 14;11(12):e0006052. doi:10.1371\/journal.pntd.0006052. PMID: 29240765; PMCID: PMC5730103.","DOI":"10.1371\/journal.pntd.0006052"},{"issue":"4","key":"10.1016\/j.ijbiomac.2025.144650_bb0065","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1017\/S0031182016002523","article-title":"Chemotherapy of leishmaniasis: present challenges","volume":"145","author":"Uliana","year":"2018","journal-title":"Parasitology"},{"key":"10.1016\/j.ijbiomac.2025.144650_bb0070","doi-asserted-by":"crossref","unstructured":"Sundar S, Singh A. Chemotherapeutics of visceral leishmaniasis: present and future developments. Parasitology. 2018Apr;145(4):481\u2013489. doi:https:\/\/doi.org\/10.1017\/S0031182017002116. Epub 2017 Dec 7. PMID: 29215329; PMCID: PMC5984184.","DOI":"10.1017\/S0031182017002116"},{"issue":"13","key":"10.1016\/j.ijbiomac.2025.144650_bb0075","doi-asserted-by":"crossref","first-page":"1101007","DOI":"10.3389\/fphar.2022.1101007","article-title":"Editorial: drug repurposing and polypharmacology: a synergistic approach in multi-target-based drug discovery","volume":"20","author":"Rudrapal","year":"2022","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.ijbiomac.2025.144650_bb0080","doi-asserted-by":"crossref","unstructured":"Kabir A, Muth A. Polypharmacology: the science of multi-targeting molecules. Pharmacol. Res. 2022Feb; 176:106055. doi:https:\/\/doi.org\/10.1016\/j.phrs.2021.106055. Epub 2022 Jan 3. PMID: 34990865.","DOI":"10.1016\/j.phrs.2021.106055"},{"issue":"1","key":"10.1016\/j.ijbiomac.2025.144650_bb0085","doi-asserted-by":"crossref","first-page":"23","DOI":"10.2174\/13816128113199990470","article-title":"Network pharmacology strategies toward multi-target anticancer therapies: from computational models to experimental design principles","volume":"20","author":"Tang","year":"2014","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.ijbiomac.2025.144650_bb0090","doi-asserted-by":"crossref","unstructured":"Reverte M, Eren RO, Jha B, Desponds C, Sn\u00e4k\u00e4 T, Prevel F, Isorce N, Lye LF, Owens KL, Gazos Lopes U, Beverley SM, Fasel N. The antioxidant response favors Leishmania parasites survival, limits inflammation and reprograms the host cell metabolism. PLoS Pathog. 2021Mar 25;17(3): e1009422. doi:10.1371\/journal.ppat.1009422. PMID: 33765083; PMCID: PMC7993605.","DOI":"10.1371\/journal.ppat.1009422"},{"key":"10.1016\/j.ijbiomac.2025.144650_bb0095","doi-asserted-by":"crossref","unstructured":"Ali V, Behera S, Nawaz A, Equbal A, Pandey K. Unique thiol metabolism in trypanosomatids: redox homeostasis and drug resistance. Adv. Parasitol. 2022; 117:75\u2013155. doi:https:\/\/doi.org\/10.1016\/bs.apar.2022.04.002. Epub 2022 Jun 30. PMID: 35878950.","DOI":"10.1016\/bs.apar.2022.04.002"},{"key":"10.1016\/j.ijbiomac.2025.144650_bb0100","doi-asserted-by":"crossref","unstructured":"Kima PE. Leishmania molecules that mediate intracellular pathogenesis. Microbes Infect. 2014Sep;16(9):721\u20136. doi:https:\/\/doi.org\/10.1016\/j.micinf.2014.07.012. Epub 2014 Aug 5. PMID: 25107580.","DOI":"10.1016\/j.micinf.2014.07.012"},{"key":"10.1016\/j.ijbiomac.2025.144650_bb0105","doi-asserted-by":"crossref","unstructured":"Garc\u00eda-Soriano JC, de Lucio H, Elvira-Bl\u00e1zquez D, Alc\u00f3n-Calder\u00f3n M, Sanz Del Olmo N, S\u00e1nchez-Murcia PA, Ortega P, de la Mata FJ, Jim\u00e9nez-Ruiz A. The repertoire of iron superoxide dismutases from Leishmania infantum as targets in the search for therapeutic agents against leishmaniasis. J Enzyme Inhib Med Chem. 2024Dec;39(1):2377586. doi:https:\/\/doi.org\/10.1080\/14756366.2024.2377586. Epub 2024 Jul 22. PMID: 39037009; PMCID: PMC11571740.","DOI":"10.1080\/14756366.2024.2377586"},{"issue":"3","key":"10.1016\/j.ijbiomac.2025.144650_bb0110","first-page":"324","article-title":"Stage-specific differential gene expression of glutathione peroxidase in Leishmania major and Leishmania tropica","volume":"9","author":"Amiri-Dashatan","year":"2020","journal-title":"Rep. Biochem. Mol. Biol."},{"issue":"15","key":"10.1016\/j.ijbiomac.2025.144650_bb0115","doi-asserted-by":"crossref","first-page":"1834","DOI":"10.2174\/1381612826666201211115329","article-title":"Trypanothione metabolism as drug target for Trypanosomatids","volume":"27","author":"Pi\u00f1eyro","year":"2021","journal-title":"Curr. Pharm. Des."},{"issue":"1","key":"10.1016\/j.ijbiomac.2025.144650_bb0120","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1186\/s13071-024-06562-5","article-title":"Ascorbate peroxidase modulation confirms key role in Leishmania infantum oxidative defence","volume":"17","author":"Santos","year":"2024","journal-title":"Parasit. Vectors"},{"key":"10.1016\/j.ijbiomac.2025.144650_bb0125","doi-asserted-by":"crossref","unstructured":"Mes\u00edas, AC, Garg, NJ, Zago, MP. Redox balance keepers and possible cell functions managed by redox homeostasis in Trypanosoma cruzi. Front. Cell. Infect. Microbiol. 2019Dec 20; 9:435. doi:https:\/\/doi.org\/10.3389\/fcimb.2019.00435. PMID: 31921709; PMCID: PMC6932984.","DOI":"10.3389\/fcimb.2019.00435"},{"key":"10.1016\/j.ijbiomac.2025.144650_bb0130","doi-asserted-by":"crossref","unstructured":"Olin-Sandoval V, Moreno-S\u00e1nchez R, Saavedra E. Targeting trypanothione metabolism in trypanosomatid human parasites. Curr. Drug Targets 2010 Dec;11(12):1614\u201330. doi:https:\/\/doi.org\/10.2174\/1389450111009011614. (PMID: 20735352).","DOI":"10.2174\/1389450111009011614"},{"key":"10.1016\/j.ijbiomac.2025.144650_bb0135","doi-asserted-by":"crossref","unstructured":"Singh S, Sarma S, Katiyar SP, Das M, Bhardwaj R, Sundar D, Dubey VK. Probing the molecular mechanism of hypericin-induced parasite death provides insight into the role of spermidine beyond redox metabolism in Leishmania donovani. Antimicrob Agents Chemother. 2015Jan;59(1):15\u201324. doi:https:\/\/doi.org\/10.1128\/AAC.04169-14. Epub 2014 Oct 13. PMID: 25313212; PMCID: PMC4291343.","DOI":"10.1128\/AAC.04169-14"},{"key":"10.1016\/j.ijbiomac.2025.144650_bb0140","doi-asserted-by":"crossref","unstructured":"Santi AMM Murta SMF Antioxidant defence system as a rational target for Chagas disease and Leishmaniasis chemotherapy Mem. Inst. Oswaldo Cruz 2022 117 https:\/\/doi.org\/10.1590\/0074-02760210401 e210401 35239945.","DOI":"10.1590\/0074-02760210401"},{"key":"10.1016\/j.ijbiomac.2025.144650_bb0145","doi-asserted-by":"crossref","unstructured":"Beig, M, Oellien, F, Garoff, L, Noack, S, Krauth-Siegel, RL, Selzer, PM. Trypanothione reductase. 2015Jun 4;9(6): e0003773. doi: 10.1371\/journal.pntd.0003773. PMID: 26042772; PMCID: PMC4456413.","DOI":"10.1371\/journal.pntd.0003773"},{"issue":"11","key":"10.1016\/j.ijbiomac.2025.144650_bb0150","doi-asserted-by":"crossref","first-page":"939","DOI":"10.2174\/1389557517666170315145410","article-title":"Trypanothione reductase: a target for the development of anti- Trypanosoma cruzi drugs","volume":"17","author":"V\u00e1zquez","year":"2017","journal-title":"Mini-Rev. Med. Chem."},{"issue":"4","key":"10.1016\/j.ijbiomac.2025.144650_bb0155","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1159\/000237914","article-title":"Antitrypanosomal activity of trivalent antimonials in vitro and its significance","volume":"26","author":"Ercoli","year":"1980","journal-title":"Chemotherapy"},{"issue":"7","key":"10.1016\/j.ijbiomac.2025.144650_bb0160","doi-asserted-by":"crossref","first-page":"2824","DOI":"10.1128\/AAC.01568-08","article-title":"Trypanothione reductase high-throughput screening campaign identifies novel classes of inhibitors with antiparasitic activity","volume":"53","author":"Holloway","year":"2009","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ijbiomac.2025.144650_bb0165","doi-asserted-by":"crossref","unstructured":"Turcano L, Torrente E, Missineo A, Andreini M, Gramiccia M, Di Muccio T, Genovese I, Fiorillo A, Harper S, Bresciani A, Colotti G, Ilari A. Identification, and binding mode of a novel Leishmania Trypanothione reductase inhibitor from high throughput screening. PLoS Negl. Trop. Dis. 2018 Nov 26;12(11): e0006969. doi:10.1371\/journal.pntd.0006969. PMID: 30475811; PMCID: PMC6283646.","DOI":"10.1371\/journal.pntd.0006969"},{"key":"10.1016\/j.ijbiomac.2025.144650_bb0170","doi-asserted-by":"crossref","unstructured":"Fiorillo A, Colotti G, Boffi A, Baiocco P, Ilari A (2012) The crystal structures of the Tryparedoxin-Tryparedoxin peroxidase couple unveil the structural determinants of Leishmania detoxification pathway. PLoS Negl. Trop. Dis. 6(8): e1781. doi:https:\/\/doi.org\/10.1371\/journal.pntd.0001781.","DOI":"10.1371\/journal.pntd.0001781"},{"issue":"2","key":"10.1016\/j.ijbiomac.2025.144650_bb0175","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1111\/j.1365-2958.2008.06154.x","article-title":"Crucial role of cytosolic tryparedoxin peroxidase in Leishmania donovani survival, drug response and virulence","volume":"68","author":"Iyer","year":"2008","journal-title":"Mol. Microbiol."},{"issue":"5","key":"10.1016\/j.ijbiomac.2025.144650_bb0180","doi-asserted-by":"crossref","first-page":"9705","DOI":"10.1038\/srep09705","article-title":"Structure-based discovery of the first non-covalent inhibitors of Leishmania major tryparedoxin peroxidase by high throughput docking","volume":"7","author":"Brindisi","year":"2015","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ijbiomac.2025.144650_bb0185","doi-asserted-by":"crossref","unstructured":"Mittra B, Laranjeira-Silva MF, Miguel DC, Perrone Bezerra de Menezes J, Andrews NW. The iron-dependent mitochondrial superoxide dismutase SODA promotes Leishmania virulence. J Biol Chem. 2017Jul 21;292(29):12324\u201312338. doi:https:\/\/doi.org\/10.1074\/jbc.M116.772624. Epub 2017 May 26. PMID: 28550086; PMCID: PMC5519379.","DOI":"10.1074\/jbc.M116.772624"},{"key":"10.1016\/j.ijbiomac.2025.144650_bb0190","doi-asserted-by":"crossref","unstructured":"Wilkinson SR, Obado SO, Mauricio IL, Kelly JM. Trypanosoma cruzi expresses a plant-like ascorbate-dependent hemoperoxidase localized to the endoplasmic reticulum. Proc Natl Acad Sci U S A. 2002Oct 15;99(21):13453\u20138. doi:https:\/\/doi.org\/10.1073\/pnas.202422899. Epub 2002 Sep 26. PMID: 12351682; PMCID: PMC129694.","DOI":"10.1073\/pnas.202422899"},{"key":"10.1016\/j.ijbiomac.2025.144650_bb0195","doi-asserted-by":"crossref","unstructured":"Freeman SL, Skafar V, Kwon H, Fielding AJ, Moody PCE, Mart\u00ednez A, Issoglio FM, Inchausti L, Smircich P, Zeida A, Piacenza L, Radi R, Raven EL. Crystal structure of Trypanosoma cruzi heme peroxidase and characterization of its substrate specificity and compound I intermediate. J. Biol. Chem. 2022Aug;298(8):102204. doi:https:\/\/doi.org\/10.1016\/j.jbc.2022.102204. (Epub 2022 Jun 27. PMID: 35772495; PMCID: PMC9358470).","DOI":"10.1016\/j.jbc.2022.102204"},{"issue":"Pt 2","key":"10.1016\/j.ijbiomac.2025.144650_bb0200","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1042\/BJ20050311","article-title":"Leishmania major encodes an unusual peroxidase that is a close homologue of plant ascorbate peroxidase: a novel role of the transmembrane domain","volume":"390","author":"Adak","year":"2005","journal-title":"Biochem. J."},{"key":"10.1016\/j.ijbiomac.2025.144650_bb0205","doi-asserted-by":"crossref","unstructured":"Dolai S, Yadav RK, Datta AK, Adak S. Effect of thiocyanate on the peroxidase and pseudocatalase activities of Leishmania major ascorbate peroxidase. Biochim. Biophys. Acta 2007Feb;1770(2):247\u201356. doi:https:\/\/doi.org\/10.1016\/j.bbagen.2006.10.001. Epub 2006 Oct 5. PMID: 17118560.","DOI":"10.1016\/j.bbagen.2006.10.001"},{"key":"10.1016\/j.ijbiomac.2025.144650_bb0210","doi-asserted-by":"crossref","unstructured":"Dolai S, Yadav RK, Pal S, Adak S. Overexpression of mitochondrial Leishmania major ascorbate peroxidase enhances tolerance to oxidative stress-induced programmed cell death and protein damage. Eukaryot Cell. 2009 Nov;8(11):1721\u201331. doi:https:\/\/doi.org\/10.1128\/EC.00198-09. Epub 2009Sep 11. PMID: 19749178; PMCID: PMC2772409.","DOI":"10.1128\/EC.00198-09"},{"key":"10.1016\/j.ijbiomac.2025.144650_bb0215","doi-asserted-by":"crossref","unstructured":"Kumar A, Das S, Purkait B, Sardar AH, Ghosh AK, Dikhit MR, Abhishek K, Das P. Ascorbate peroxidase, a key molecule regulating amphotericin B resistance in clinical isolates of Leishmania donovani. Antimicrob Agents Chemother. 2014Oct;58(10):6172\u201384. doi:https:\/\/doi.org\/10.1128\/AAC.02834-14. Epub 2014 Aug 11. Erratum in: Antimicrob Agents Chemother. 2022 Aug 16;66(8): e0082922. doi:https:\/\/doi.org\/10.1128\/aac.00829-22. PMID: 25114128; PMCID: PMC4187981.","DOI":"10.1128\/AAC.02834-14"},{"key":"10.1016\/j.ijbiomac.2025.144650_bb0220","doi-asserted-by":"crossref","unstructured":"Mansuri R Kumar A Rana S Panthi B Ansari MY Das S Dikhit MR Sahoo GC Das P In vitro evaluation of antileishmanial activity of computationally screened compounds against ascorbate peroxidase to combat amphotericin B drug resistance Antimicrob. Agents Chemother. 2017 61 7 https:\/\/doi.org\/10.1128\/AAC.02429-16 e02429-16 28461317.","DOI":"10.1128\/AAC.02429-16"},{"key":"10.1016\/j.ijbiomac.2025.144650_bb0225","doi-asserted-by":"crossref","unstructured":"Ponte-Sucre A, Gamarro F, Dujardin JC, Barrett MP, L\u00f3pez-V\u00e9lez R, Garc\u00eda-Hern\u00e1ndez R, Pountain AW, Mwenechanya R, Papadopoulou B. Drug resistance and treatment failure in leishmaniasis: a 21st century challenge. PLoS Negl. Trop. Dis. 2017Dec 14;11(12): e0006052. doi:10.1371\/journal.pntd.0006052. PMID: 29240765; PMCID: PMC5730103.","DOI":"10.1371\/journal.pntd.0006052"},{"issue":"3","key":"10.1016\/j.ijbiomac.2025.144650_bb0230","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1086\/514704","article-title":"Lipid formulations of amphotericin B: clinical efficacy and toxicities","volume":"27","author":"Wong-Beringer","year":"1998","journal-title":"Clin. Infect. Dis."},{"issue":"11","key":"10.1016\/j.ijbiomac.2025.144650_bb0235","doi-asserted-by":"crossref","first-page":"2576","DOI":"10.1093\/jac\/dks275","article-title":"Miltefosine: a review of its pharmacology and therapeutic efficacy in the treatment of leishmaniasis","volume":"67","author":"Dorlo","year":"2012","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.ijbiomac.2025.144650_bb0240","doi-asserted-by":"crossref","unstructured":"Pokharel P Ghimire R Lamichhane P Efficacy and safety of paromomycin for visceral leishmaniasis: a systematic review J. Trop. Med. 2021 8629039 https:\/\/doi.org\/10.1155\/2021\/8629039 2021 34349806.","DOI":"10.1155\/2021\/8629039"},{"key":"10.1016\/j.ijbiomac.2025.144650_bb0245","doi-asserted-by":"crossref","unstructured":"Piccica M Lagi F Bartoloni A Zammarchi L Efficacy and safety of pentamidine isethionate for tegumentary and visceral human leishmaniasis: a systematic review J. Travel Med. 2021 28 6 https:\/\/doi.org\/10.1093\/jtm\/taab065 taab065 33890115.","DOI":"10.1093\/jtm\/taab065"},{"key":"10.1016\/j.ijbiomac.2025.144650_bb0250","doi-asserted-by":"crossref","unstructured":"Sundar S, Chakravarty J. Antimony toxicity. Int J Environ Res Public Health. 2010Dec;7(12):4267\u201377. doi:https:\/\/doi.org\/10.3390\/ijerph7124267. Epub 2010 Dec 20. PMID: 21318007; PMCID: PMC3037053.","DOI":"10.3390\/ijerph7124267"},{"key":"10.1016\/j.ijbiomac.2025.144650_bb0255","doi-asserted-by":"crossref","unstructured":"Tiuman TS, Santos AO, Ueda-Nakamura T, Filho BP, Nakamura CV. Recent advances in leishmaniasis treatment. Int. J. Infect. Dis. 2011Aug;15(8):e525\u201332. doi:https:\/\/doi.org\/10.1016\/j.ijid.2011.03.021. Epub 2011 May 24. PMID: 21605997.","DOI":"10.1016\/j.ijid.2011.03.021"},{"issue":"1","key":"10.1016\/j.ijbiomac.2025.144650_bb0260","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1007\/s40506-015-0038-4","article-title":"Cutaneous leishmaniasis: current treatment practices in the USA for returning travelers","volume":"7","author":"Eiras","year":"2015","journal-title":"Curr. Treat. Options Infect. Dis."},{"key":"10.1016\/j.ijbiomac.2025.144650_bb0265","doi-asserted-by":"crossref","unstructured":"Steimbach LM, Tonin FS, Virtuoso S, Borba HH, Sanches AC, Wiens A, Fernandez-Llim\u00f3s F, Pontarolo R. Efficacy, and safety of amphotericin B lipid-based formulations-a systematic review and meta-analysis. Mycoses 2017Mar;60(3):146\u2013154. doi:https:\/\/doi.org\/10.1111\/myc.12585. Epub 2016 Nov 22. PMID: 27878878.","DOI":"10.1111\/myc.12585"},{"issue":"4","key":"10.1016\/j.ijbiomac.2025.144650_bb0270","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1016\/S1473-3099(10)70320-0","article-title":"Visceral leishmaniasis: elimination with existing interventions","volume":"11","author":"Matlashewski","year":"2011","journal-title":"Lancet Infect. Dis."},{"issue":"2","key":"10.1016\/j.ijbiomac.2025.144650_bb0275","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1007\/s40262-017-0570-0","article-title":"Clinical pharmacokinetics of systemically administered antileishmanial drugs","volume":"57","author":"Kip","year":"2018","journal-title":"Clin. Pharmacokinet."},{"issue":"5","key":"10.1016\/j.ijbiomac.2025.144650_bb0280","doi-asserted-by":"crossref","first-page":"1654","DOI":"10.1093\/nar\/gkm1180","article-title":"Pentamidine binds to tRNA through non-specific hydrophobic interactions and inhibits aminoacylation and translation","volume":"36","author":"Sun","year":"2008","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.ijbiomac.2025.144650_bb0285","doi-asserted-by":"crossref","unstructured":"Sundar S Singh J Dinkar A Agrawal N Safety and effectiveness of miltefosine in post-kala-azar dermal leishmaniasis: an observational study Open Forum Infect. Dis. 2023 ofad231 https:\/\/doi.org\/10.1093\/ofid\/ofad231 10 5 37234513.","DOI":"10.1093\/ofid\/ofad231"},{"key":"10.1016\/j.ijbiomac.2025.144650_bb0290","unstructured":"Sundar, S, Olliaro, PL. Miltefosine in the treatment of leishmaniasis: clinical evidence for informed clinical risk management. Ther. Clin. Risk Manag. 2007Oct;3(5):733\u201340. PMID: 18472998; PMCID: PMC2376078."},{"key":"10.1016\/j.ijbiomac.2025.144650_bb0295","doi-asserted-by":"crossref","first-page":"323","DOI":"10.2147\/TCRM.S30139","article-title":"Interest in paromomycin for the treatment of visceral leishmaniasis (kala-azar)","volume":"8","author":"Wiwanitkit","year":"2012","journal-title":"Ther. Clin. Risk Manag."},{"key":"10.1016\/j.ijbiomac.2025.144650_bb0300","doi-asserted-by":"crossref","unstructured":"Pokharel P Ghimire R Lamichhane P Efficacy and safety of paromomycin for visceral leishmaniasis: a systematic review J. Trop. Med. 2021 https:\/\/doi.org\/10.1155\/2021\/8629039 2021 934349806.","DOI":"10.1155\/2021\/8629039"},{"key":"10.1016\/j.ijbiomac.2025.144650_bb0305","doi-asserted-by":"crossref","unstructured":"Hopkins AL. Network pharmacology: the next paradigm in drug discovery. Nat. Chem. Biol. 2008Nov;4(11):682\u201390. doi:https:\/\/doi.org\/10.1038\/nchembio.118. (PMID: 18936753).","DOI":"10.1038\/nchembio.118"},{"key":"10.1016\/j.ijbiomac.2025.144650_bb0310","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1038\/nrd1468","article-title":"Drug repositioning: identifying and developing new uses for existing drugs","volume":"3","author":"Ashburn","year":"2004","journal-title":"Nat. Rev. Drug Discov."},{"issue":"15","key":"10.1016\/j.ijbiomac.2025.144650_bb0315","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1016\/S1359-6446(04)03163-0","article-title":"From magic bullets to designed multiple ligands","volume":"9","author":"Morphy","year":"2004","journal-title":"Drug Discov. Today"},{"issue":"46","key":"10.1016\/j.ijbiomac.2025.144650_bb0320","doi-asserted-by":"crossref","first-page":"6935","DOI":"10.2174\/1381612822666160923115828","article-title":"Polypharmacology in precision oncology: current applications and future prospects","volume":"22","author":"Antolin","year":"2016","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.ijbiomac.2025.144650_bb0325","doi-asserted-by":"crossref","unstructured":"Ferrari, SM, Fallahi, P, Politti, U, Materazzi, G, Baldini, E, Ulisse, S, Miccoli, P, Antonelli, A. Molecular targeted therapies of aggressive thyroid cancer. Front. Endocrinol. (Lausanne). 2015 Nov 20; 6:176. https:\/\/doi.org\/10.3389\/fendo.2015.00176. PMID: 26635725; PMCID: PMC4653714.","DOI":"10.3389\/fendo.2015.00176"},{"issue":"9","key":"10.1016\/j.ijbiomac.2025.144650_bb0330","doi-asserted-by":"crossref","first-page":"3716","DOI":"10.1158\/0008-5472.CAN-04-3700","article-title":"Dual inhibition of epidermal growth factor receptor and vascular endothelial growth factor receptor phosphorylation by AEE788 reduces growth and metastasis of human colon carcinoma in an orthotopic nude mouse model","volume":"65","author":"Yokoi","year":"2005","journal-title":"Cancer Res."},{"key":"10.1016\/j.ijbiomac.2025.144650_bb0335","doi-asserted-by":"crossref","unstructured":"Hooper, DC. Mechanisms of action and resistance of older and newer fluoroquinolones. Clin. Infect. Dis. 2000 31 Suppl 2: S24-8. https:\/\/doi.org\/10.1086\/314056. (PMID: 10984324).","DOI":"10.1086\/314056"},{"key":"10.1016\/j.ijbiomac.2025.144650_bb0340","doi-asserted-by":"crossref","unstructured":"Schr\u00f6der W, Tzschentke TM, Terlinden R, De Vry J, Jahnel U, Christoph T, Tallarida RJ. Synergistic interaction between the two mechanisms of action of tapentadol in analgesia. J Pharmacol Exp Ther. 2011Apr;337(1):312\u201320. doi:https:\/\/doi.org\/10.1124\/jpet.110.175042. Epub 2011 Jan 24. Erratum in: J Pharmacol Exp Ther. 2012 Jul;342(1):232. Erratum in: J Pharmacol Exp Ther. 2014 Mar;348(3):489. PMID: 21262850; PMCID: PMC3364495.","DOI":"10.1124\/jpet.110.175042"},{"issue":"21","key":"10.1016\/j.ijbiomac.2025.144650_bb0345","doi-asserted-by":"crossref","first-page":"6523","DOI":"10.1021\/jm058225d","article-title":"Designed multiple ligands. An emerging drug discovery paradigm","volume":"48","author":"Morphy","year":"2005","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ijbiomac.2025.144650_bb0350","doi-asserted-by":"crossref","unstructured":"Overington JP, Al-Lazikani B, Hopkins AL. How many drug targets are there? Nat. Rev. Drug Discov. 2006Dec;5(12):993\u20136. doi:https:\/\/doi.org\/10.1038\/nrd2199. (PMID: 17139284).","DOI":"10.1038\/nrd2199"},{"key":"10.1016\/j.ijbiomac.2025.144650_bb0355","doi-asserted-by":"crossref","unstructured":"Lai CJ, Bao R, Tao X, Wang J, Atoyan R, Qu H, Wang DG, Yin L, Samson M, Forrester J, Zifcak B, Xu GX, DellaRocca S, Zhai HX, Cai X, Munger WE, Keegan M, Pepicelli CV, Qian C. CUDC-101, a multi-targeted inhibitor of histone deacetylase, epidermal growth factor receptor, and human epidermal growth factor receptor 2, exerts potent anticancer activity. Cancer Res. 2010May 1;70(9):3647\u201356. doi:https:\/\/doi.org\/10.1158\/0008-5472.CAN-09-3360. Epub 2010 Apr 13. PMID: 20388807.","DOI":"10.1158\/0008-5472.CAN-09-3360"},{"key":"10.1016\/j.ijbiomac.2025.144650_bb0360","doi-asserted-by":"crossref","first-page":"112931","DOI":"10.1016\/j.ejmech.2020.112931","article-title":"Polypharmacological drug actions of recently FDA approved antibiotics","volume":"209","author":"Wetzel","year":"2021","journal-title":"Eur. J. Med. Chem."},{"issue":"1","key":"10.1016\/j.ijbiomac.2025.144650_bb0365","doi-asserted-by":"crossref","first-page":"131","DOI":"10.25259\/IJDVL_191_20","article-title":"Ozenoxacin: a novel topical antibiotic","volume":"87","author":"Santhosh","year":"2021","journal-title":"Indian J. Dermatol. Venereol. Leprol."},{"issue":"8","key":"10.1016\/j.ijbiomac.2025.144650_bb0370","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1007\/s40265-022-01725-z","article-title":"Delafloxacin: a review in community-acquired pneumonia","volume":"82","author":"Lee","year":"2022","journal-title":"Drugs"},{"issue":"29","key":"10.1016\/j.ijbiomac.2025.144650_bb0375","doi-asserted-by":"crossref","first-page":"4697","DOI":"10.2147\/IDR.S205309","article-title":"Evaluating cefiderocol in the treatment of multidrug-resistant gram-negative Bacilli: a review of the emerging data","volume":"13","author":"Giacobbe","year":"2020","journal-title":"Infect. Drug Resist."},{"issue":"2","key":"10.1016\/j.ijbiomac.2025.144650_bb0380","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1634\/theoncologist.2014-0177","volume":"20","author":"Tzogani","year":"2015","journal-title":"Oncologist"},{"key":"10.1016\/j.ijbiomac.2025.144650_bb0385","unstructured":"European Medicines Agency. Cabometyx. Available online: https:\/\/www.ema.europa.eu\/en\/documents\/product-information\/cabometyx-epar-product-information_en.pdf."},{"key":"10.1016\/j.ijbiomac.2025.144650_bb0390","unstructured":"European Medicines Agency. Sutent. Available online: https:\/\/www.ema.europa.eu\/en\/documents\/product-information\/sutent-epar-product-information_en.pdf."},{"key":"10.1016\/j.ijbiomac.2025.144650_bb0395","doi-asserted-by":"crossref","unstructured":"O'Brien S, Patel M, Kahl BS, Horwitz SM, Foss FM, Porcu P, Jones J, Burger J, Jain N, Allen K, Faia K, Douglas M, Stern HM, Sweeney J, Kelly P, Kelly V, Flinn I. Duvelisib, an oral dual PI3K-\u03b4, \u03b3 inhibitor, shows clinical and pharmacodynamic activity in chronic lymphocytic leukemia and small lymphocytic lymphoma in a phase 1 study. Am J Hematol. 2018 Nov;93(11):1318\u20131326. doi:https:\/\/doi.org\/10.1002\/ajh.25243. Epub 2018Oct 20. PMID: 30094870; PMCID: PMC8260004.","DOI":"10.1002\/ajh.25243"},{"issue":"13","key":"10.1016\/j.ijbiomac.2025.144650_bb0400","doi-asserted-by":"crossref","first-page":"1070660","DOI":"10.3389\/fimmu.2022.1070660","article-title":"Safety and efficacy of dual PI3K-\u03b4, \u03b3 inhibitor, duvelisib in patients with relapsed or refractory lymphoid neoplasms: a systematic review and meta-analysis of prospective clinical trials","volume":"4","author":"Wang","year":"2023","journal-title":"Front. Immunol."},{"issue":"9","key":"10.1016\/j.ijbiomac.2025.144650_bb0405","doi-asserted-by":"crossref","first-page":"1590","DOI":"10.1158\/2159-8290.CD-23-1376","article-title":"Efficacy of the allosteric MEK inhibitor Trametinib in relapsed and refractory juvenile myelomonocytic leukemia: a report from the children\u2019s oncology group","volume":"14","author":"Stieglitz","year":"2024","journal-title":"Cancer Discov."},{"key":"10.1016\/j.ijbiomac.2025.144650_bb0410","doi-asserted-by":"crossref","unstructured":"Bora K, Sarma M, Kanaujia SP, Dubey VK. Development of novel dual-target drugs against visceral leishmaniasis and combinational study with miltefosine. Free Radic. Biol. Med. 2024 Nov 20;225:275\u2013285. doi:https:\/\/doi.org\/10.1016\/j.freeradbiomed.2024.10.257. Epub 2024Oct 10. PMID: 39388970.","DOI":"10.1016\/j.freeradbiomed.2024.10.257"},{"issue":"2","key":"10.1016\/j.ijbiomac.2025.144650_bb0415","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/j.exppara.2013.07.021","article-title":"Evaluation of a diospyrin derivative as antileishmanial agent and potential modulator of ornithine decarboxylase of Leishmania donovani","volume":"135","author":"Hazra","year":"2013","journal-title":"Exp. Parasitol."},{"issue":"6","key":"10.1016\/j.ijbiomac.2025.144650_bb0420","doi-asserted-by":"crossref","first-page":"444","DOI":"10.5483\/BMBRep.2008.41.6.444","article-title":"Modeled structure of trypanothione reductase of Leishmania infantum","volume":"41","author":"Singh","year":"2008","journal-title":"BMB Rep."}],"container-title":["International Journal of Biological Macromolecules"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S014181302505202X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S014181302505202X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,19]],"date-time":"2026-04-19T04:07:02Z","timestamp":1776571622000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S014181302505202X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6]]},"references-count":84,"alternative-id":["S014181302505202X"],"URL":"https:\/\/doi.org\/10.1016\/j.ijbiomac.2025.144650","relation":{},"ISSN":["0141-8130"],"issn-type":[{"value":"0141-8130","type":"print"}],"subject":[],"published":{"date-parts":[[2025,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Targeting antioxidant defense system enzymes for Leishmaniasis treatment","name":"articletitle","label":"Article Title"},{"value":"International Journal of Biological Macromolecules","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijbiomac.2025.144650","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"144650"}}